On September 29, 2022, PanCAN brought together a panel of research and treatment experts for an in-depth discussion on the latest in pancreatic cancer research.
- The latest scientific advances in precision medicine, immunotherapy, drug development, early detection and screening for high-risk individuals.
- How PanCAN’s Precision Promise clinical trial platform and the PanCAN Early Detection Initiative are revolutionizing pancreatic cancer detection and treatment.
- The importance of PanCAN’s comprehensive approach to investing in research, which ensures that the pancreatic cancer field is collaborative and keeps the patient at the center.
- PanCAN’s record-breaking research investment of almost $25 million, bringing PanCAN’s total research investment to $174 million to date, all thanks to generous donors.
Julie M. Fleshman, JD, MBA
PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes
Lynn Matrisian, PhD, MBA
PanCAN Chief Science Officer, leading our research and clinical initiatives, including the PanCAN Early Detection Initiative, PanCAN's Research Grants Program and more
Andrew Lowy, MD
Surgical Oncologist and Chief of the Division of Surgical Oncology at UC San Diego Health, past chair and current member of PanCAN's Scientific & Medical Advisory Board
Anirban Maitra, MBBS
Professor of Pathology and Translational Molecular Pathology and Scientific Director of the Sheikh Ahmed Pancreatic Cancer Research Center at The University of Texas MD Anderson Cancer Center, Houston, past chair and current member of PanCAN's Scientific & Medical Advisory Board
Jonathan Pachter, PhD
VerastemTM Oncology Chief Scientific Officer
Nicolette Rodriguez, MD, MPH
Instructor of Medicine at Harvard Medical School and Co-Director of Fellowship Initiatives for Trainees Underrepresented in Medicine in the Department of Medicine at Brigham and Women’s Hospital
Contact PanCAN Patient Services team
for answers to any questions you have about pancreatic cancer, treatment options and more. Our expert case managers are here from 7 a.m. to 5 p.m. PT, Monday through Friday, to help. Contact us at 877-573-9971 or email@example.com.
We’re looking forward to sharing with you the latest developments in pancreatic cancer research. Add this event to your calendar and save pancan.org/researchprogress for webinar day, Thursday, September 29, 11 a.m. PT / 2 p.m. ET. Add to Calendar
(If you're prompted to download an iCalendar file, save it to your device and open it)
Enter the email address you used to RSVP for the event.
DIDN'T RSVP? Sign up now and get immediate access to the event.